摘要
目的探讨肺栓塞(PE)患者ACA、Hcy及D-二聚体表达水平及其临床意义。方法选取本院明确诊断为PE住院患者68例及健康对照组30例,分别应用酶联免疫法、Hcy仪及血凝仪检测ACA、Hcy及D-二聚体的表达水平。结果 PE患者ACA、Hcy、D-二聚体含量均明显高于对照组,并且随着PE患者的病情加重,ACA、Hcy及D-二聚体表达水平越高,差异有统计学意义(P<0.05)。结论 PE患者ACA、Hcy及D-二聚体的表达水平明显升高,并且与PE患者疾病的严重程度呈正相关,可作为PE患者的诊断、治疗及预后的重要检测指标。
Objective： To investigate the expression and clinical significance of ACA,Hcy（ homocysteine） and D-dimer in patients with pulmonary embolism. Methods： Sixty-eight cases of hospitalized patients with pulmonary embolism and 30 cases of healthy control group were selected. The expression levels of ACA,Hcy and D-dimer were detected by enzyme-linked immunoassay,homocysteine and blood coagulation analyzer respectively. Results： The levels of ACA,Hcy and D-dimer in patients with pulmonary embolism were significantly higher than those in the control group. The expression level of ACA,Hcy and D-dimer was higher with the increase of PE patients,the difference was statistically significant（ P〈0. 05）. Conclusion：ACA,Hcy and D-dimer expression levels and pulmonary embolism have obvious relevance,and patients with pulmonary embolism are positively correlated with the severity of disease,which can be used as an important indicator of the diagnosis,treatment and prognosis of patients with pulmonary embolism detection.
作者
郭洪娜
GUO Hong-na(Dept. of Clinical Laboratory, Yishui Central Hospital of LinYi City, Yishui 276400, Chin)
出处
《泰山医学院学报》
CAS
2017年第9期991-992,共2页
Journal of Taishan Medical College
